(MENAFN- GlobeNewsWire - Nasdaq) Rising Geriatric Population and Increased Awareness of Menopause Management Fuel 5.31% CAGR Expansion during 2026–2035.Austin, United States, April 06, 2026 (GLOBE NEWSWIRE) -- As per SNS Insider, the Hormone Replacement Therapy Market size was valued at USD 20.36 Billion in 2025 and is projected to reach USD 34.16 Billion by 2035, growing at a CAGR of 5.31% during 2026–2035. A number of factors, including the frequency of hormonal imbalances, an aging population, and increased knowledge of hormone-related ailments, have contributed to the steady rise of the Hormone Replacement Therapy (HRT) industry.
Get a Sample Report of Hormone Replacement Therapy Market:
The U.S. Hormone Replacement Therapy Market has been valued at USD 6.85 Billion in 2025 and is expected to reach USD 11.02 Billion in 2035, growing at a CAGR of 4.86% over 2026-2035. Growth of Hormone Replacement in the U.S. is due to due to higher diagnosis rates, established clinical guidelines, and broader insurance coverage. Prescription trends are influenced by evolving safety data, while demand for transdermal and bioidentical therapies has increased over the past few years.
Market Growth is Driven by Rising Prevalence of Hormonal Disorders Globally
The growing prevalence of hormonal abnormalities linked to aging, especially in menopausal women and those with endocrine illnesses, is the main reason propelling the market for hormone replacement therapy. Demand is being further increased by growing knowledge of the advantages of hormone replacement therapy (HRT) in enhancing quality of life and controlling symptoms like weariness, hot flashes, and osteoporosis. The market is expanding as a result of improvements in medication delivery technologies, improved access to healthcare, and encouraging clinical research.
Segmentation Analysis:
By Product Type
In 2025, Estrogen Replacement Therapy dominated with 38% share due to its widespread application in the treatment of symptoms related to menopause globally. Testosterone Replacement Therapy is the fastest-growing product type due to the increased incidence rate of hypogonadism and the growing awareness among men regarding their health.
By Route of Administration
In 2025, Oral segment dominated with 42% share due to its ease of use, availability, and cost-effectiveness. The transdermal segment is growing at a high rate due to its benefits, such as low side effects, increased hormone absorption, and high compliance.
By Application
In 2025, Menopause Management dominated with 49% share as HRT is commonly employed to manage various menopause-related problems and enhance quality of life. Hypogonadism has been observed to be the fastest-growing segment, owing to increasing diagnosis rates and awareness about hormonal deficiencies in men.
By End-User
In 2025, Hospitals dominated with 46% share as they have the facilities and the expertise to diagnose and treat hormone-related conditions. The availability of more user-friendly treatments and the growing inclination toward self-administered hormone therapy are the main reasons why homecare is the end-user market with the quickest rate of growth.
Need Any Customization Research on Hormone Replacement Therapy Market, Enquire Now:
Regional Insights:
With 41% of the global market share in 2025, North America leads the hormone replacement therapy industry. High knowledge of hormonal abnormalities, particularly in the treatment of menopause, is the driving force behind this dominance.
Due in large part to increased knowledge of hormone levels and illnesses including menopause and endocrine disorders, the Asia-Pacific market for hormone replacement therapy is expanding quickly.
Recent Developments:
In March 2024, Pfizer continued to invest in research and development to expand its portfolio of hormone and endocrine therapies, focusing on improving treatment outcomes and patient quality of life. In April 2024, Novartis focused on advancing its research capabilities and expanding its product portfolio through strategic collaborations and innovations in hormone-related therapies, aiming to enhance treatment effectiveness and accessibility.
Major Hormone Replacement Therapy Companies Analysis Listed in the Report are
Pfizer Inc. Novartis AG Bayer AG AbbVie Inc. Novo Nordisk A/S Eli Lilly and Company Merck KGaA Hoffmann-La Roche Ltd. Teva Pharmaceutical Industries Ltd. Viatris Inc. Amgen Inc. AstraZeneca plc Sanofi S.A. GlaxoSmithKline plc Ipsen Pharma Endo International plc Allergan (AbbVie Inc.) Mylan N.V. (Viatris) Sun Pharmaceutical Industries Ltd. Cipla Limited
Hormone Replacement Therapy Market Segmentation
By Product Type
Estrogen Replacement Therapy Progesterone Replacement Therapy Combination Hormone Therapy Testosterone Replacement Therapy Thyroid Hormone Therapy
By Route of Administration
Oral Transdermal Injectable Vaginal
By Application
Menopause Management Hypogonadism Growth Hormone Deficiency Hypothyroidism Others
By End User
Hospitals Clinics Homecare Settings
Exclusive Sections of the Report (The USPs):
ENVIRONMENTAL COMPLIANCE METRICS – helps you understand regulatory approvals, safety guidelines, and compliance standards governing hormone replacement therapies across global healthcare markets. CAPACITY UTILIZATION RATES – helps you identify healthcare infrastructure utilization, patient treatment volumes, and capacity of clinics and hospitals to manage rising hormone therapy demand. SUPPLY CHAIN DISRUPTION INDEX – helps you analyze risks in raw material sourcing, pharmaceutical manufacturing, and distribution of hormone-based medications across regions. TECHNOLOGICAL ADOPTION RATE – helps you uncover trends in adoption of advanced delivery methods, bioidentical hormones, and personalized therapy solutions in hormone replacement treatment. COMPETITIVE LANDSCAPE – helps you gauge the competitive strength of key players based on product portfolios, innovation in therapies, regional presence, and strategic collaborations. PATIENT DEMAND & TREATMENT TRENDS – helps you evaluate growth in therapy adoption, rising awareness of hormonal disorders, and increasing demand for menopause and endocrine health treatments.
Purchase Single User PDF of Hormone Replacement Therapy Market Report (20% Discount):
Hormone Replacement Therapy Market Report Scope
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
CONTACT: Contact Us:
Rohan Jadhav - Principal Consultant
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Email:...
Comments
No comment